Biomedicines,
Год журнала:
2021,
Номер
9(10), С. 1313 - 1313
Опубликована: Сен. 24, 2021
Attention-deficit/hyperactivity
disorder
(ADHD)
is
a
prevalent
and
serious
neurodevelopmental
characterized
by
symptoms
of
inattention
and/or
hyperactivity/impulsivity.
Chronic
childhood
stress
involved
in
ADHD
development,
highly
comorbid
with
anxiety.
Similarly,
inflammatory
diseases
pro-inflammatory
state
have
been
associated
ADHD.
However,
while
several
works
studied
the
relationship
between
peripheral
inflammation
affective
disorders
such
as
depression
or
bipolar
disorder,
fewer
explored
this
association
In
narrative
review
we
synthetize
evidence
showing
an
interplay
stress,
anxiety,
immune
dysregulation
ADHD,
discuss
implications
potential
disrupted
neuroendocrine
response
Moreover,
highlight
confounding
factors
limitations
existing
studies
on
topic
critically
debate
multidirectional
hypotheses
that
either
suggest
inflammation,
anxiety
cause
pathophysiology
consequence
disease.
Untangling
these
relationships
will
diagnostic,
therapeutic
prognostic
for
patients.
Translational Psychiatry,
Год журнала:
2019,
Номер
9(1)
Опубликована: Сен. 18, 2019
Abstract
Inflammation
is
a
natural
defence
response
of
the
immune
system
against
environmental
insult,
stress
and
injury,
but
hyper-
hypo-inflammatory
responses
can
trigger
diseases.
Accumulating
evidence
suggests
that
inflammation
involved
in
multiple
psychiatric
disorders.
Using
inflammation-related
factors
as
biomarkers
disorders
requires
proof
reproducibility
specificity
changes
different
disorders,
which
remains
to
be
established.
We
performed
cross-disorder
study
by
systematically
evaluating
meta-analysis
results
eight
major
including
schizophrenia
(SCZ),
bipolar
disorder
(BD),
autism
spectrum
(ASD),
depression
(MDD),
post-trauma
(PTSD),
sleeping
(SD),
obsessive–compulsive
(OCD)
suicide.
A
total
43
meta-analyses
involving
704
publications
on
44
were
included
study.
calculated
effect
size
statistical
power
for
every
factor
each
disorder.
Our
analyses
showed
well-powered
case–control
studies
provided
more
consistent
than
underpowered
when
one
was
meta-analysed
researchers.
After
removing
studies,
30
significant
alterations
at
least
based
meta-analyses.
Eleven
them
changed
patients
two
compared
with
controls.
few
unique
specific
(e.g.,
IL-4
increased
BD,
decreased
suicide,
had
no
change
MDD,
ASD,
PTSD
SCZ).
MDD
largest
number
while
SD
has
least.
Clustering
analysis
closely
related
share
similar
patterns
inflammatory
changes,
genome-wide
genetic
have
found.
According
obtained
from
meta-analyses,
13
would
need
<50
cases
50
controls
achieve
80%
show
differences
(
p
<
0.0016)
between
Changes
states
SCZ
or
BD
also
observed
various
comparisons.
Studies
comparing
first-episode
may
reproducible
findings
those
pre-
post-treatment
results.
Longitudinal,
system-wide
regulation
differentiate
trait-
state-specific
will
needed
establish
valuable
biomarkers.
Current Nutrition Reports,
Год журнала:
2020,
Номер
9(3), С. 171 - 182
Опубликована: Май 13, 2020
Abstract
Purpose
of
Review
Probiotics
are
living
bacteria,
which
when
ingested
in
adequate
amounts,
confer
health
benefits.
Gut
microbes
suggested
to
play
a
role
many
psychiatric
disorders
and
could
be
potential
therapeutic
target.
Between
the
gut
brain,
there
is
bi-directional
communication
pathway
called
microbiota-gut-brain
axis.
The
purpose
this
review
examine
data
from
recent
interventional
studies
focusing
on
probiotics
gut-brain
axis
for
treatment
depression,
anxiety
schizophrenia.
Recent
Findings
likely
improve
depression
but
not
Regarding
anxiety,
only
one
trial
showed
an
effect
multispecies
probiotic.
However,
determinants
like
duration
treatment,
dosage
interactions
have
been
thoroughly
investigated
deserve
more
scientific
attention.
Summary
Microbiome-based
therapies
such
as
cautiously
recommended
enhance
beneficial
bacteria
mood
through
JAMA Psychiatry,
Год журнала:
2020,
Номер
78(2), С. 161 - 161
Опубликована: Окт. 20, 2020
Importance
Observational
studies
highlight
associations
of
C-reactive
protein
(CRP),
a
general
marker
inflammation,
and
interleukin
6
(IL-6),
cytokine-stimulating
CRP
production,
with
individual
depressive
symptoms.
However,
it
is
unclear
whether
inflammatory
activity
associated
symptoms
to
what
extent
metabolic
dysregulation
underlies
the
reported
associations.
Objective
To
explore
genetic
overlap
between
activity,
dysregulation,
GWAS
Data
Sources
Genome-wide
association
study
(GWAS)
summary
data
European
individuals,
including
following:
levels
(204
402
individuals);
9
(3
which
did
not
differentiate
underlying
diametrically
opposite
[eg,
insomnia
hypersomnia])
as
measured
Patient
Health
Questionnaire
(up
117
907
statistics
for
major
depression,
excluding
UK
Biobank
participants,
resulting
in
sample
sizes
500
199
up
230
214
respectively;
386
533
body
mass
index
(BMI)
322
154
height
253
280
individuals).
Design
In
this
correlation
2-sample
mendelian
randomization
(MR)
study,
linkage
disequilibrium
score
(LDSC)
regression
was
applied
infer
single-nucleotide
variant–based
heritability
estimates.
Two-sample
MR
tested
potential
causal
variants
levels,
IL-6
signaling,
BMI
The
dates
were
November
2019
April
2020.
Results
Based
on
large
GWAS
sources,
analyses
revealed
consistent
false
discovery
rate
(FDR)–controlled
(genetic
range,
0.152-0.362;
FDRP
=
.006
toP
<
.001)
that
similar
size
correlations
suggested
upregulation
signaling
suicidality
(estimate
[SE],
0.035
[0.010];
FDR
plus
Bonferroni
correctionP
.01),
finding
remained
stable
across
statistical
models
sensitivity
using
alternative
instrument
selection
strategies.
Mendelian
consistently
show
higher
or
other
symptoms,
but
anhedonia,
tiredness,
changes
appetite,
feelings
inadequacy.
Conclusions
Relevance
This
reports
coheritability
may
result
from
potentially
also
found
suicidality.
These
findings
have
clinical
implications,
highlighting
anti-inflammatory
approaches,
especially
blockade,
putative
strategy
suicide
prevention.
Abstract
Background
The
Gut-Brain-Axis
is
a
bidirectional
signaling
pathway
between
the
gastrointestinal
(GI)
tract
and
brain.
hundreds
of
trillions
microorganisms
populating
are
thought
to
modulate
this
connection,
have
far
reaching
effects
on
immune
system,
central
autonomic
nervous
systems,
GI
functioning.
These
interactions
Diagnostic
statistical
manual
mental
disorders
also
been
linked
various
psychiatric
illnesses
such
as
depression,
anxiety,
substance
abuse,
autism
spectrum
disorder,
eating
disorders.
It
hypothesized
that
techniques
aimed
at
strengthening
repopulating
gut
microbiome,
Fecal
Microbiota
Transplant
(FMT),
may
be
useful
in
prevention
treatment
illnesses.
Methods
A
systematic
search
five
databases
was
conducted
using
key
terms
related
FMT
All
results
were
then
evaluated
based
specific
eligibility
criteria.
Results
Twenty-one
studies
met
criteria
analysed
for
reported
changes
mood
behavioural
measures
indicative
wellbeing.
included
either
entirely
clinical
(
n
=
8),
preclinical
with
human
donors
9),
or
11).
found
decrease
depressive
anxiety-like
symptoms
behaviours
resulting
from
transplantation
healthy
microbiota.
inverse
found,
transmission
microbiota
psychiatrically
ill
recipients.
Conclusion
There
appears
strong
evidence
through
FMT.
Further
research
larger
sample
sizes
stronger
scientific
design
warranted
order
fully
determine
efficacy
safety
potential
treatment.
Registered
PROSPERO,
IRD:
CRD42019126795.
Pharmaceuticals,
Год журнала:
2022,
Номер
15(10), С. 1203 - 1203
Опубликована: Сен. 28, 2022
Major
depressive
disorder
(MDD)
is
a
common
and
complex
mental
disorder,
that
adversely
impacts
an
individual’s
quality
of
life,
but
its
diagnosis
treatment
are
not
accurately
executed
symptom-based
approach
utilized
in
most
cases,
due
to
the
lack
precise
knowledge
regarding
pathophysiology.
So
far,
first-line
treatments
still
based
on
monoamine
neurotransmitters.
Even
though
there
lot
progress
this
field,
mechanisms
seem
get
more
confusing,
also
getting
controversial.
In
study,
we
try
review
broad
advances
neurotransmitters
field
MDD,
update
effects
many
advanced
neuroscience
studies.
We
propose
hypothesis
paid
special
attention
their
new
pathways
for
such
as
inflammation,
oxidative
stress,
neurotrophins,
neurogenesis,
especially
glial
cells,
which
have
recently
been
found
play
important
role
neurodegenerative
disorders,
including
MDD.
addition,
will
extend
basic
emotions;
suggested
our
previous
reports,
three
different
roles
emotions:
dopamine—joy,
norepinephrine—fear
(anger),
serotonins—disgust
(sadness).
Above
all,
paper
tries
give
full
picture
relationship
between
MDD
DA,
NE,
5-HT,
well
contributions
Three
Primary
Color
Model
Basic
Emotions
(joy,
fear,
disgust).
This
done
by
explaining
contribution
from
sides
digestive
tract,
astrocytes,
microglial,
others,
very
briefly
addressing
potential
therapeutic
patients
reasons
limited
clinical
efficacy,
side
effects,
delayed
onset
action.
hope
might
offer
pharmacological
management
Journal of Clinical Medicine,
Год журнала:
2023,
Номер
12(4), С. 1630 - 1630
Опубликована: Фев. 17, 2023
Due
to
the
key
role
of
tumor
necrosis
factor-alpha
(TNF-α)
in
pathogenesis
immunoinflammatory
diseases,
TNF-α
inhibitors
have
been
successfully
developed
and
used
clinical
treatment
autoimmune
disorders.
Currently,
five
anti-TNF-α
drugs
approved:
infliximab,
adalimumab,
golimumab,
certolizumab
pegol
etanercept.
Anti-TNF-α
biosimilars
are
also
available
for
use.
Here,
we
will
review
historical
development
as
well
present
potential
future
applications
therapies,
which
led
major
improvements
patients
with
several
such
rheumatoid
arthritis
(RA),
ankylosing
spondylitis
(AS),
Crohn’s
disease
(CD),
ulcerative
colitis
(UC),
psoriasis
(PS)
chronic
endogenous
uveitis.
Other
therapeutic
areas
under
evaluation,
including
viral
infections,
e.g.,
COVID-19,
neuropsychiatric
disorders
certain
forms
cancer.
The
search
biomarkers
able
predict
responsiveness
is
discussed.